Fig. 1 (abstract P80).
Change from baseline in (A) PHQ-9 total scores and (B) GAD-7 total scores; proportion of patients experiencing 31 reduction in severity category for (C) PHQ-9 and (D) GAD-7 after treatment with onabotulinumtoxinA. GAD-7=7-item Generalized Anxiety Disorder Assessment; PHQ-9=9-item Patient Health Questionnaire. *Indicates P<0.0001 versus baseline. †Indicates P<0.001 for between group comparison